Primary study · included by 1 review

Central Giant Cell Granuloma: A Decade of Institutional Experience and Curative Potential of Neoadjuvant Denosumab.

Ying Ko et al. 2026 · Ko Chih Ying, Coleman Hedley, Kim James, et al. · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026

Included by

RANK/RANKL/OPG Axis Expression and Response to Anti-RANKL Therapy in Gnathic Giant Cell Lesions: A Systematic Review and Meta-Analysis.

Non-Cochrane · other · 2026 · cited as Ying Ko 2026 · Table 2; Table 1 / Table 4; reference list

Outcome this study informs	Pooled effect	Evidence	Certainty
Clinical and radiological tumor response Denosumab	no estimate extracted	10 studies · 58 participants	GRADE not reported

1 including review in total.